These outcomes highlight the effectiveness of personalized dosing, ongoing medical support, and comprehensive lifestyle coaching working together
Related solutions Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products
While the FDA banned exact copies of GLP-1 drugs, federal law still allows compounding pharmacies to create "customized" versions tailored to individual patients
This includes stimulating insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting a sense of fullness, all of which contribute to its efficacy in managing obesity and type 2 diabetes
In some cases, temporary dose reduction, switching to an alternative GLP-1 preparation, or clinician-supervised, short-term anti-emetic medication may be appropriate